Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults

Human Immunology

Volumn 71, Issue 12, 2010, Pages 1187-1190

  Yin, Zhinan ^a   Fujii, Hajime ^b   Walshe, Thomas ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Amino Up Chemical Co   (Japan)

^c Academic Research Associates   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

AHCC; Healthy adults; Immunoenhancer

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; GAMMA INTERFERON; HEXOSE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EVALUATION; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; NORMAL HUMAN; PRIORITY JOURNAL; SUPPLEMENTATION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MIDDLE AGED; POLYSACCHARIDES; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149412417     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.08.006     Document Type: Article

References (21)

1. Kidd P.M. The use of mushrooms glycans and proteoglycans in cancer treatment. Altern Med Rev 2000, 5:4-27.
2. Matsui Y., Uhara J., Satoi S., Kaibori M., Yamada H., Kitade H., et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: A prospective cohort study. J Hepatol 2002, 37:78-86.
3. Borchers A.T., Stern J.S., Hackman R.M., Keen C.L., Gershwin M.E. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 1999, 221:281-293.
4. Mizuno T., Yeohlui P., Kinoshita T., Zhuang C., Ito H., Mayuzumi Y. Antitumor activity and chemical modification of polysaccharides from nioshimeji mushroom. Biosci Biotechnol Biochem 1996, 60:30-33.
5. Sakagami H., Aoki T. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK. Anticancer Res 1991, 11:993-1000.
6. Wasser S.P., Weis A.L. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: A modern perspective. Crit Rev Immunol 1999, 19:65-69.
7. Aviles H., O'donnell P., Orshal J., Fujii H., Sun B., Sonnenfeld G. Active hexose correlated compound activates immune function to decrease bacterial load in amurine model of intramuscular infection. Am J Surg 2008, 195:537-545.
8. Ghoneum M., Wimbley M., Salem F., Mcklain A., Attallah N., Gill G. Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC). Int J Immunother 1995, 11:23-28.
9. Matsushita K., Kuramitsu Y., Ohiro Y., Obara M., Kobayashi M., Li Y., Hosokawa M. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anti Cancer Drugs 1998, 9:343-350.
10. Ye S., Ichimura K., Wakame K., Ohe M. Suppressive effects of active hexose correlated compound on the increased activity of hepatic and renal ornithine decarboxilase induced by oxidative stress. Life Sci 2003, 74:593-602.
11. Terakawa N., Matsui Y., Satoi S., Yanagimoto H., Takahashi A., Yamamoto T., et al. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: A double-blind, placebo-controlled trial. Nutr Cancer 2008, 60:643-651.
12. Burikhanov R.B., Wakame K., Igarashi Y., Wang S., Matsuzaki S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr Regul 2000, 34:181-188.
13. Wakame K. Protective effects of active hexose correlated compound (AHCC) on the onset of diabetes induced by storeptozotocin in rats. Biomed Resour 1999, 20:145-152.
14. Aviles H., Belay T., Vance M., Sun B., Sonnenfeld G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol 2004, 97:1437-1444.
15. Mamdooh G., Phyllis P., Yasuo N., Mabrouk G., Gus G. Enhancement of NK cell activity in cancer patients by active hemicellulose compound (AHCC). Adjuvant Nutrition in Cancer Treatment Symposium 1992 November 6-7, 1992, Tulsa, OK.
16. Yagita A., Maruyama S., Fujituka M., Ohshima K. Novel immunotherapy using a human natural (Hn) IL-12 inducer. Jpn J Cancer Res 1998, 89:2422.
17. Yagita A., Maruyama S., Wakasugi S., Sukegawa Y. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo 2002, 16:49-54.
18. Aviles H., Belay T., Fountain K., Vance M., Sun B., Sonnenfeld G. Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol 2003, 95:491-496.
19. Gao Y., Zhang D., Sun B., Fujii H., Kosuna K., Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother 2006, 55. 1528-266.
20. Suni M.A., Picker L.J., Maino V.C. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1998, 212:89-98.
21. Matsui K., Kawaguchi Y., Ozaki T., Tokuhara K., Kaibori M., Matsui Y., et al. Effect of active hexose correlated compound on the production of nitric oxide in hepatocytes. J Parenter Enteral Nutr 2007, 31:373-380.